Espaven indications
Topical/Cutaneous
Head pediculosis
Adult: A 4% solution is used for treatment.
Child: >6 mth: A 4% solution is used for treatment.
Topical/Cutaneous
As a skin protectant
Adult: As cream containing Espaven 22% w/w and benzalkonium chloride 0.1% w/w. Apply to the affected area several times a day as needed.
Espaven description
Espaven contains dimethicone (silicone) 15%, cetyl alcohol (hexadecanol) 5% and glycerol 2%, in a lanolin-free cream base. It also contains methylhydroxybenzoate 0.2% and propylhydroxybenzoate 0.1% as preservatives. It has a pH of 6.
Espaven does not contain perfume, lanolin or lanolin derivatives.
Espaven dosage
Adults: Improvement of Abdominal Symptoms Due to Gas in the Gastrointestinal Tract: 120-240 mg daily divided into 3 times after or between meals by oral route.
Elimination of Foamy Mucus in the Stomach Prior to Gastric Endoscopy: 40-80 mg with about 10 mL of water at 15-40 min prior to the test by oral route.
Elimination of Gas in the Intestine Prior to Abdominal X-Ray Examination: 120-240 mg daily divided into 3 times after or between meals for 3-4 days prior to the test by oral route.
Some adjustments may be made according to the age and symptom of the patient.
Administration: Espaven Drops: Shake and then use.
Espaven interactions
Do not take this product if you are presently taking a prescription antibiotic drug of any form of tetracycline.
The rate and/or extent of absorption of many drugs may be increased or decreased when they are used concurrently with antacids.
Therefore, as a general rule, medication should not be taken within one to two hours of an antacid, if possible.
An incomplete list of substances for which the above statement has been shown to apply includes: tetracycline, iron sans, chlorpromazine, levodopa, isoniazid, digoxin, H2-antagonists, indomethacin, nitrofurantin, and dicumard.
An increase in the plasma level of quinidine and possible toxicity may result if alkalization of the urine occurs during antacid therapy.
Espaven side effects
Adverse reactions were reported in 16 of 2546 patients (0.63%) treated with Espaven. The most frequently observed adverse reactions were soft stools in 8 patients (0.31%), gastric discomfort in 4 patients (0.16%), diarrhea in 3 patients (0.12%) and stomachache in 3 patients (0.12%). No abnormal changes were reported in laboratory tests. (At the end of the re-evaluation.) See Table 2.
Espaven contraindications
Tuberculous, viral lesions of the skin (e.g. herpes simplex and varicella); fungal lesions not susceptible to nystatin, facial rosacea, acne vulgaris or perioral dermatitis. Not to be applied to the external auditory canal in patients with perforated tympanic membranes. Do not use on extensive areas to reduce risk of systemic absorption and neomycin-induced ototoxicity. Not recommended for <1 yr.
Active ingredient matches for Espaven:
Dimeticone in Argentina, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Peru.
Calcium Pantothenate/Dimethicone
Metoclopramide/Pantothenic Acid in Argentina, Mexico.
Ranitidine in Argentina, Mexico.
Calcium pantothenate/Metoclopramide/Pantothenic Acid in Mexico.
| Unit description / dosage (Manufacturer) | Price, USD |
| Tablet; Oral; Dimethicone 40 mg; Vitamin B5 / Calcium Pantothenate 50 mg | |
List of Espaven substitutes (brand and generic names): | |
| Espasmo Canulase (Peru) | |
| Tablet; Oral; Amylase 2100 IU; Cellulasum 0.9 FIP; Dimethicone 20 mg; Glutamic Acid Hydrochloride 100 mg; Lipase 1200 IU; Methixene Hydrochloride 1 mg; Pepsini Pulvis 120 units; Protease 80 IU; Sodium Dehydrocholate 20 mg (Novartis consumer) | |
| Espaven Pediátrico (Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama) | |
| Suspension; Oral; Dimethicone 500 mg / 5 ml | |
| Suspension; Oral; Dimethicone 500 mg / 5 ml | |
| Especticom (Mexico) | |
| Esputicon (Poland) | |
| Eticplus (Paraguay) | |
| EtoPril (Germany) | |
| Etos Ranitidine (Netherlands) | |
| Exac (Bangladesh) | |
| Exhantil (Mexico) | |
| Exhidrol (Mexico) | |
| Ezopta (Greece) | |
| Faboacid (Argentina) | |
| Faboacid R (Paraguay) | |
| Faboacid-R (Argentina) | |
| Fada Ranitidina (Argentina) | |
| Fagus (Spain) | |
| Fasten | |
| Fasten 150 mg Tablet (Medihands Pharmaceuticals) | $ 0.01 |
| Fendibina (Argentina) | |
| Finigas (Brazil) | |
| Flatex (Brazil) | |
| Flatmed (Mexico) | |
| Flatol (Brazil) | |
| Flatol Max (Brazil) | |
| For Gas (Brazil) | |
| Fordin (Indonesia) | |
| Fordin 150 mg x 3 x 10's (Promed) | $ 13.95 |
| Fordin 50 mg/2 mL x 5's (Promed) | $ 9.30 |
| Fozab (Pakistan) | |
| Freegas (Brazil) | |
| Fripi Flash (Argentina) | |
| FuWei (China) | |
| Fydom-R | |
| Fydom-R Ranitidine 150mg, Domperidone20mg TAB / 10 | |
| Fydom-R Ranitidine 150mg, Domperidone20mg TAB / 10 | |
| Fydon-R | |
| Fydon-R Ranitidine 150mg, Ondansetron4mg TAB / 10 | |
| Fydon-R Ranitidine 150mg, Ondansetron4mg TAB / 10 | |
| G-Ranitidine (Bangladesh) | |
| Gadean (Vietnam) | |
| Gadean 150 mg x 10 Blister x 10 Tablet | |
| Galebiron (Greece) | |
| Galidrin (Mexico) | |
| Injectable; Injection; Ranitidine Hydrochloride 25 mg / ml (Probiomed) | |
| Tablet; Oral; Ranitidine Hydrochloride 150 mg (Probiomed) | |
| Tablets; Oral; Ranitidine Hydrochloride 150 mg (Probiomed) | |
| Gaproxen (Greece) | |
See 3110 substitutes for Espaven | |
References
- DailyMed. "PANTOTHENIC ACID: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DailyMed. "CALCIUM: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "DIMETHICONE". https://pubchem.ncbi.nlm.nih.gov/sub... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Espaven are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Espaven. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yet4 consumers reported age
| Users | % | ||
|---|---|---|---|
| > 60 | 3 | 75.0% | |
| 46-60 | 1 | 25.0% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
